232 related articles for article (PubMed ID: 20421009)
1. Impact of race and ethnicity on outcomes for estrogen receptor-negative breast cancers: experience of an academic center with a charity hospital.
Chu QD; Burton G; Glass J; Smith MH; Li BD
J Am Coll Surg; 2010 May; 210(5):585-92, 592-4. PubMed ID: 20421009
[TBL] [Abstract][Full Text] [Related]
2. Race/Ethnicity has no effect on outcome for breast cancer patients treated at an academic center with a public hospital.
Chu QD; Smith MH; Williams M; Panu L; Johnson LW; Shi R; Li BD; Glass J
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2157-61. PubMed ID: 19622718
[TBL] [Abstract][Full Text] [Related]
3. Racial differences in estrogen receptor staining levels and implications for treatment and survival among estrogen receptor positive, HER2-negative invasive breast cancers.
Purrington KS; Gorski D; Simon MS; Hastert TA; Kim S; Rosati R; Schwartz AG; Ratnam M
Breast Cancer Res Treat; 2020 May; 181(1):145-154. PubMed ID: 32236827
[TBL] [Abstract][Full Text] [Related]
4. Does race predict survival for women with invasive breast cancer?
Walsh SM; Zabor EC; Stempel M; Morrow M; Gemignani ML
Cancer; 2019 Sep; 125(18):3139-3146. PubMed ID: 31206623
[TBL] [Abstract][Full Text] [Related]
5. Race and ethnicity and breast cancer outcomes in an underinsured population.
Komenaka IK; Martinez ME; Pennington RE; Hsu CH; Clare SE; Thompson PA; Murphy C; Zork NM; Goulet RJ
J Natl Cancer Inst; 2010 Aug; 102(15):1178-87. PubMed ID: 20574040
[TBL] [Abstract][Full Text] [Related]
6. Racial disparity in estrogen receptor positive breast cancer patients receiving trimodality therapy.
Wright JL; Reis IM; Zhao W; Panoff JE; Takita C; Sujoy V; Gomez CR; Jorda M; Franceschi D; Hurley J
Breast; 2012 Jun; 21(3):276-83. PubMed ID: 22178596
[TBL] [Abstract][Full Text] [Related]
7. Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial.
Sparano JA; Wang M; Zhao F; Stearns V; Martino S; Ligibel JA; Perez EA; Saphner T; Wolff AC; Sledge GW; Wood WC; Davidson NE
J Natl Cancer Inst; 2012 Mar; 104(5):406-14. PubMed ID: 22250182
[TBL] [Abstract][Full Text] [Related]
8. Racial/Ethnic Disparities in Survival after Breast Cancer Diagnosis by Estrogen and Progesterone Receptor Status: A Pooled Analysis.
John EM; McGuire V; Kurian AW; Koo J; Shariff-Marco S; Gomez SL; Cheng I; Keegan THM; Kwan ML; Bernstein L; Vigen C; Wu AH
Cancer Epidemiol Biomarkers Prev; 2021 Feb; 30(2):351-363. PubMed ID: 33355191
[TBL] [Abstract][Full Text] [Related]
9. Influence of clinical, societal, and treatment variables on racial differences in ER-/PR- breast cancer survival.
Roseland ME; Schwartz K; Ruterbusch JJ; Lamerato L; Krajenta R; Booza J; Simon MS
Breast Cancer Res Treat; 2017 Aug; 165(1):163-168. PubMed ID: 28547656
[TBL] [Abstract][Full Text] [Related]
10. Socioeconomic and Racial Disparities in Cancer Stage at Diagnosis, Tumor Size, and Clinical Outcomes in a Large Cohort of Women with Breast Cancer, 2007-2016.
Hardy D; Du DY
J Racial Ethn Health Disparities; 2021 Aug; 8(4):990-1001. PubMed ID: 32914344
[TBL] [Abstract][Full Text] [Related]
11. The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care.
Freedman RA; Virgo KS; He Y; Pavluck AL; Winer EP; Ward EM; Keating NL
Cancer; 2011 Jan; 117(1):180-9. PubMed ID: 20939011
[TBL] [Abstract][Full Text] [Related]
12. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.
Lund MJ; Trivers KF; Porter PL; Coates RJ; Leyland-Jones B; Brawley OW; Flagg EW; O'Regan RM; Gabram SG; Eley JW
Breast Cancer Res Treat; 2009 Jan; 113(2):357-70. PubMed ID: 18324472
[TBL] [Abstract][Full Text] [Related]
13. Racial disparities in treatment and survival of women with stage I-III breast cancer at a large academic medical center in metropolitan Detroit.
Du W; Simon MS
Breast Cancer Res Treat; 2005 Jun; 91(3):243-8. PubMed ID: 15952057
[TBL] [Abstract][Full Text] [Related]
14. Prognosis among African-American women and white women with lymph node negative breast carcinoma: findings from two randomized clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP).
Dignam JJ; Redmond CK; Fisher B; Costantino JP; Edwards BK
Cancer; 1997 Jul; 80(1):80-90. PubMed ID: 9210712
[TBL] [Abstract][Full Text] [Related]
15. Outcome for patients with triple-negative breast cancer is not dependent on race/ethnicity.
Chu QD; Henderson AE; Ampil F; Li BD
Int J Breast Cancer; 2012; 2012():764570. PubMed ID: 22645687
[TBL] [Abstract][Full Text] [Related]
16. Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.
Silber JH; Rosenbaum PR; Ross RN; Reiter JG; Niknam BA; Hill AS; Bongiorno DM; Shah SA; Hochman LL; Even-Shoshan O; Fox KR
Milbank Q; 2018 Dec; 96(4):706-754. PubMed ID: 30537364
[TBL] [Abstract][Full Text] [Related]
17. Socioeconomic factors and breast cancer in black and white Americans.
Gordon NH
Cancer Metastasis Rev; 2003 Mar; 22(1):55-65. PubMed ID: 12716037
[TBL] [Abstract][Full Text] [Related]
18. The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004.
Brown M; Tsodikov A; Bauer KR; Parise CA; Caggiano V
Cancer; 2008 Feb; 112(4):737-47. PubMed ID: 18189290
[TBL] [Abstract][Full Text] [Related]
19. The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review.
Vona-Davis L; Rose DP
J Womens Health (Larchmt); 2009 Jun; 18(6):883-93. PubMed ID: 19514831
[TBL] [Abstract][Full Text] [Related]
20. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry.
Bauer KR; Brown M; Cress RD; Parise CA; Caggiano V
Cancer; 2007 May; 109(9):1721-8. PubMed ID: 17387718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
